Data-Driven Precision Medicine
The Power of AI to Personalise Treatment
LEADING DIAGNOSTIC COMPANY PROVIDING
PREDICTIVE
PROGNOSTIC
TREATMENTS
OUR PRODUCTS
PERSONALISED
xT: SOLID TUMOR
- SOLID TUMOR
- Analyses both germline and somatic mutations
- Provides:
- FDA-approved treatments
- Clinical trial eligibility
- Clinical decision for treatment of solid tumours
xF: LIQUID BIOPSY
- LIQUID BIOPSY
- Analyses Tumor Burden in Advanced Tumor.
- Provides:
- FDA-approved treatments
- Clinical decision for treatment of solid tumours
- Clinical trial eligibility
For any medical enquiry,
Contact us at +91 9591736262 or
Email us at info@sayretherapeutics.com